What is Wall Street analysts’ target price for Edwards Lifesciences stock?
Valued with a market capitalization of $45.7 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases. The Irvine, California-based company is known for its patient-centered approach and close collaboration with physicians. This healthcare company has underperformed the broader market over the past 52 weeks. EW shares have gained 10.9% during…